MabThera 1400 mg concentrate for solution for infusion

Licence status
Authorised:
Active substances
Rituximab
Dosage Form
Solution for injection
Licence number
EU/1/98/067/003
Licence holder
Roche Registration GmbH

Product documents

Licence information

ATC code
L01XC02 rituximab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued

Educational materials for patients